Recombinant Rat VISTA/B7-H5/PD-1H Fc Chimera Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 2288-B7

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
2288-B7-050
Print Quote
Bulk Order
100% Guarantee

Key Product Details

Source

NS0

Accession #

NP_001037765.1

Structure / Form

Disulfide-linked homodimer

Conjugate

Unconjugated

Applications

Bioactivity

View all VISTA/B7-H5/PD-1H Proteins and Enzymes »

Product Specifications

Source

Mouse myeloma cell line, NS0-derived rat VISTA/B7-H5/PD-1H protein
Rat VISTA
(Met1-Ala192)
Accession # NP_001037765.1		 IEGRMD Human IgG1
(Pro100-Lys330)
N-terminus C-terminus

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Ile33

Predicted Molecular Mass

44.6 kDa

SDS-PAGE

60-70 kDa, reducing conditions

Activity

Measured by its ability to inhibit anti-CD3 antibody induced IFN-gamma secretion by human peripheral blood mononuclear cells (PBMC).
The ED50 for this effect is 1-6 μg/mL.

Scientific Data Images for Recombinant Rat VISTA/B7-H5/PD-1H Fc Chimera Protein, CF

Recombinant Rat VISTA/B7-H5/PD-1H Fc Chimera Protein Bioactivity

Recombinant Rat VISTA/B7-H5/PD-1H Fc Chimera Protein Bioactivity

Recombinant Rat VISTA/B7-H5/PD-1H Fc Chimera (Catalog # 2288-B7) inhibits IFN-gamma secretion by human peripheral blood mononuclear cells in the presence of anti-CD3 antibody. The ED50 for this effect is 1-6 μg/mL.
Recombinant Rat VISTA/B7-H5/PD-1H Fc Chimera Protein SDS-PAGE

Recombinant Rat VISTA/B7-H5/PD-1H Fc Chimera Protein SDS-PAGE

2 μg/lane of Recombinant Rat VISTA/B7-H5/PD-1H was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 60-70 kDa and 120-140 kDa, respectively.

Formulation, Preparation and Storage

2288-B7
Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution Reconstitute at 200 μg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
  • 12 months from date of receipt, ≤ -20 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, ≤ -20 °C under sterile conditions after reconstitution.

Background: VISTA/B7-H5/PD-1H

V-domain Ig suppressor of T cell activation (VISTA), also known as platelet receptor Gi24, Dies1, SISP1, PD-1H, and B7‑H5, is a 50-60 kDa transmembrane glycoprotein with homology to B7-like immune co-stimulatory molecules (1, 2). Mature rat VISTA contains a 160 amino acid (aa) extracellular domain (ECD) with one Ig-like domain, a 24 aa transmembrane segment, and a 96 aa cytoplasmic domain. The ECD of rat VISTA shares a 78% and 67% aa sequence identity with mouse and human VISTA, respectively. In human VISTA, a 30 kDa ECD can be shed by MT1‑MMP, leaving a 25-30 kDa fragment remaining in the membrane (3). VISTA promotes both MT1‑MMP expression and the MT1-MMP mediated activation of MMP-2 (3). VISTA has been shown to support the differentiation of embryonic stem cells (ESC) and enhances BMP-4 induced signaling in ESC, but it is also down-regulated following BMP-4 exposure (4, 5). Vista can bind directly to BMP-4, but it also associates with the type I BMP receptor Activin RIB/ALK 4 (4, 5). VISTA is highly expressed on mature CD11b high myeloid-derived APCs and to a lesser extent on CD4+, CD8+, and T regs and is also found on tumor infiltrating lymphocytes (7). It is up-regulated in vivo on activated monocytes and dendritic cells (5). VISTA inhibits CD4+ and CD8+ T cell proliferation, and their production of IL2 and IFN-gamma (6). Its expression on tumor cells attenuates the antitumor immune response and enables more rapid tumor progression (6). Suppression of VISTA signaling was shown to increase the rate of progression in the mouse autoimmune disease model EAE (6). VISTA-Ig suppressed proliferation of T cells but not B cells and blunted the production of T cell cytokines and activation markers, suggesting that VISTA as a negative checkpoint regulator suppresses T cell activation (8, 9).

References

  1. Flajnik, M.F. et al. (2012) Immunogenetics 64:571.
  2. Wilcox, R.A. et al. (2012) Eur. J. Haematol. 88:465.
  3. Sakr, M.A. et al. (2010) Cancer Sci. 101:2368.
  4. Aloia, L. et al. (2010) J. Biol. Chem.285:7776.
  5. Parisi, S. et al. (2012) FASEB J. 26:3957.
  6. Wang, L. et al. (2011) J. Exp. Med. 208:577.
  7. Flies, D.B. et al. (2014) J Clin Invest. 124:1966.
  8. Lines, J.L. et al. (2014) Cancer Res. 74:1924.
  9. Nowak, E.C. et al. (2017) Immunol Rev. 276:66.

Alternate Names

4632428N05Rik, B7-H5, C10orf54, Dies1, Gi24, PD-1H, PD1H, SISP1, VSIR

Entrez Gene IDs

64115 (Human); 74048 (Mouse); 690899 (Rat); 102116468 (Cynomolgus Monkey)

Gene Symbol

VSIR

UniProt

NP_001037765.1

Additional VISTA/B7-H5/PD-1H Products

Product Documents for Recombinant Rat VISTA/B7-H5/PD-1H Fc Chimera Protein, CF

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Rat VISTA/B7-H5/PD-1H Fc Chimera Protein, CF

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.